+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant



Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant



Journal of Pediatrics 120(2 Part 2): S18-S24



Pulmonary mechanics and energetics were determined in 32 neonates with respiratory distress syndrome, who were randomly assigned to receive treatment with an exogenous synthetic surfactant, Exosurf Neonatal, or air placebo. Pulmonary mechanics were measured before and 2 hours after surfactant (n = 13) or air placebo (n = 19) treatment, then longitudinally at 24, 48, and 72 hours after treatment, and again at 7, 14, and 28 days of age. There were no significant differences in the values for pulmonary mechanics or energetics 2 hours after the first dose of surfactant. Improvement in pulmonary mechanics was apparent 24 hours after surfactant treatment, when dynamic compliance was 36% greater than in the placebo group (p < 0.03). Lung compliance values were also higher in surfactant-treated infants 48 and 72 hours after treatment, with a maximal increase of 64% at 7 days of age (p < 0.03). Surfactant treatment also caused a significant decrease in total pulmonary resistance at 48 and 72 hours after initial treatment and at 14 days of age (p < 0.04). Similarly, a decrease in flow-resistive work of breathing was demonstrated 24, 48, and 72 hours after surfactant treatment. At 28 daus of age, pulmonary mechanics were not different in the two groups. We conclude that beneficial effects of surfactant on pulmonary mechanics were not apparent 2 hours after dosing but were evident 24 hours after dosing and persisted for the first 7 to 14 days of life.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007705922

Download citation: RISBibTeXText

PMID: 1735846

DOI: 10.1016/s0022-3476(05)81228-4


Related references

Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment. Biology of the Neonate 87(4): 323-331, 2005

Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Pediatric Pulmonology 18(5): 273-278, 1994

Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study. Biology of the Neonate 70(1): 21-28, 1996

Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant. Journal Of Pediatrics. 122(3): 446-452, 1993

Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2000(2): Cd001149, 2000

Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome. Journal of Perinatal Medicine 37(5): 561-564, 2009

Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome. New England Journal of Medicine 319(8): 476-479, 1988

The effect of reconstituted bovine surfactant on pulmonary mechanics in infants with respiratory distress syndrome. Acta Paediatrica Japonica 31(6): 734-741, 1989

Indomethacin response in preterm infants with severe respiratory distress syndrome treated with human surfactant. Pediatric Research 19(4 Part 2): 354A, 1985

Fluid dynamics and renal function in preterm infants with respiratory distress syndrome treated with surfactant ta. Journal of the Iwate Medical Association 40(2): 201-210, 1988

Effects of bovine lipid extract surfactant administration in preterm infants treated for respiratory distress syndrome. Health Science Reports 1(4): E34, 2018

The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Pathology, Research and Practice 205(1): 35-41, 2009

Bronchoalveolar lavage surfactant protein a, B, and d concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. Pediatric Research 53(4): 663-670, 2003

Activities of superoxide dismutase and catalase in tracheal aspirate fluid of surfactant treated preterm infants with respiratory distress syndrome. Zeitschrift fuer Geburtshilfe und Neonatologie 203(5): 201-206, 1999

Surfactant treatment before first breath for respiratory distress syndrome in preterm lambs: comparison of a peptide-containing synthetic lung surfactant with porcine-derived surfactant. Drug Design Development and Therapy 7: 905-916, 2013